PHF13 epigenetically activates TGFβ driven epithelial to mesenchymal transition

Cell Death Dis. 2022 May 21;13(5):487. doi: 10.1038/s41419-022-04940-4.

Abstract

Epigenetic alteration is a pivotal factor in tumor metastasis. PHD finger protein 13 (PHF13) is a recently identified epigenetic reader of H3K4me2/3 that functions as a transcriptional co-regulator. In this study, we demonstrate that PHF13 is required for pancreatic-cancer-cell growth and metastasis. Integrative analysis of transcriptome and epigenetic profiles provide further mechanistic insights into the epigenetic regulation of genes associated with cell metastasis during the epithelial-to-mesenchymal transition (EMT) induced by transforming growth factor β (TGFβ). Our data suggest PHF13 depletion impairs activation of TGFβ stimulated genes and correlates with a loss of active epigenetic marks (H3K4me3 and H3K27ac) at these genomic regions. These observations argue for a dependency of TGFβ target activation on PHF13. Furthermore, PHF13-dependent chromatin regions are enriched in broad H3K4me3 domains and super-enhancers, which control genes critical to cancer-cell migration and invasion, such as SNAI1 and SOX9. Overall, our data indicate a functional and mechanistic correlation between PHF13 and EMT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Chromatin / genetics
  • Chromatin / metabolism
  • DNA-Binding Proteins* / genetics
  • Epigenesis, Genetic*
  • Epithelial Cells / metabolism
  • Epithelial-Mesenchymal Transition* / genetics
  • Humans
  • Neoplasms* / pathology
  • Transcription Factors* / genetics
  • Transforming Growth Factor beta / metabolism

Substances

  • Chromatin
  • DNA-Binding Proteins
  • PHF13 protein, human
  • Transcription Factors
  • Transforming Growth Factor beta